NCT05141110View on ClinicalTrials.gov

Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

June 29, 2022

Conditions

Healthy Subjects

Interventions

DRUG

NVP-1705

NVP-1705

DRUG

NVP-1705-R

NVP-1705-R

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NVP Healthcare

INDUSTRY